問題 左側液下腫瘤報告

不好意思，因要好幾項報告，還是下面的才是切片報告?

9/25 免疫組織化學染色(每一抗體)

Lymph node, axillary, left, core needle biopsy, carcinoma, metastatic.Description:The specimen submitted consists of 5 tissue fragments measuring up to 1.2x0.1x0.1 cm in size, fixed in formalin. Grossly, they are whitish and soft. All for section after bisection and labeled as A1-A2; Jar: 0 An/SMicroscopically, sections reveal metastatic carcinoma arranged in sheets or nests with desmoplasia in the lymphoid background. Moderately nuclear atypism is found. Marked mitotic figure is noted. The tumor cells
show TRPS1(+) by immunostain. Breast origin is favored.

IMMUNOHISTOCHEMICAL STUDY The tissue was fixed in 10% neutral buffered formalin. The fixation time of the tissue was longer than 6 hours and shorter than 72 hours.Cold Ischemia Times was less than 1 hour: Yes.Testing platform: Ventana BenchMark Series, Detection system: Ventana Ultraview DAB IHC Detection kitDESCRIPTION1. ESTROGEN RECEPTOR by VENTANA (clone: SP1) monoclonal rabbit anti-human estrogen receptor antibody: negative nuclear staining in invasive tumor cells(Internal control: absent)”No
internal controls are present, but external controls are appropriately positive. If needed, testing another specimen that contains internal controls may be warranted for confirmation of ER status.”2. PROGESTERONE RECEPTOR by VENTANA (clone: 1E2) monoclonal rabbit anti-human progesterone receptor antibody: negative nuclear staining in invasive tumor cells.(Internal control: absent)3. HER2/neu by Ventana (clone: 4B5) rabbit monoclonal anti-human c-erbB2 oncoprotein antibody: negative membrane staining in
invasive tumor cells 4. Ki-67 by Cell Marque (clone: SP6) monoclonal antibody: Percentage of positive nuclei: 45 %INTERPRETATION1. ESTROGEN RECEPTOR: negative (＜1 %).2. PROGESTERONE RECEPTOR: Negative (＜1 %).3. HER2/neu: according to ASCO/CAP Guideline Update (J Clin Oncol. 2018 Jul 10;36(20):2105-2122. The HER2/neu overexpression assessment is Negative (score 0): No staining is observed or Membrane staining that is incomplete and is faint/barely perceptible and within ≦10% of tumor cells.”This test
was developed and its performance characteristics determined by the Department of Surgical Pathology of Changhua Christian Hospital. It has been approved by the U.S. Food and Drug Administration.”This assay has not been validated on decalcified tissues. Results should be interpreted with caution given the likelihood of false negativity on decalcified specimens.4. Ki-67 proliferation index (45%)The pathologic diagnosis has been discussed and confirmed by Peer Slide Review.Dr.Wei-Hsiang Chang
Ref:K12141519, K12147007, K22126959

婆婆(68歲)左側液下就醫檢查為2cm左右腫瘤，
切片後醫生說是惡性，

目前排乳房、胸腔斷層、大腸鏡、腹部超音波都沒有發現癌症轉移

醫生說治療要連左邊乳房一起切除，並要接受化療，原本這周三或周五就可以動刀，因考慮

有預約斗六台大下周二外科門診想做確認，或是否有其他治療方式?

9/28 切片報告
Indication : Other : LT AXILLARY LYMPHADENOPATHY FOR CNB 左側 最大徑 18.15 X 12.

10/7 乳房造影術
1. Indication for examination:= Diagnostic mammogram RCC RMLO LCC LMLO2. GlandulTissue diagnosis Note: The false-negative rate of mammography is approximately l

看版友說要看分類,
但怎麼9/28的說是4A? 10/7裡面卻是4C?

-----
Sent from JPTT on my Samsung SM-A3460.

--